Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is a contract manufacturer and focuses on the manufacture and marketing of pharmaceutical products and services to clients across the globe, the portfolio includes a range of US-FDA norms producing HORMONAL preparations in Oral (Solid & Liquid) & Injectable forms, Skin Ointments & Cosmetic preparations, Oncology formulations and Contract Research and Manufacturing Services.
Akums Drugs And Pharmaceuticals Limited, is an unlisted public company incorporated on 19 April, 2004. It is classified as a public limited company and is located in , . It's authorized share capital is INR 40.00 cr and the total paid-up capital is INR 31.48 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Kewal Kundanlal Handa | 00056826 | 3 years |
Director | Matangi Gowrishankar | 01518137 | 3 years |
Managing Director | Sandeep Jain
Shareholder
|
00323476 | 21 years |
Managing Director | Sanjeev Jain
Shareholder
|
00323433 | 21 years |
Director | Satwinder Singh | 00164903 | 1 years |
Nominee Director | Sunil Kumar Thakur | 03266370 | 1 years |
Whole-time Director | Sanjay Sinha | 03627342 | 1 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
SBICap Trustee Company Limited
No. of Loans: 1
Total Amount : 280.0 cr
Oriental Bank of Commerce
No. of Loans: 1
Total Amount : 0.2 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
PURE AND CURE HEALTHCARE PRIVATE LIMITED | 2005 | ₹ 3.0 Cr | |
MALIK LIFESCIENCES PRIVATE LIMITED | Delhi | 2004 | ₹ 46.7 L |
MAXCURE NUTRAVEDICS LIMITED | Delhi | 1994 | ₹ 5.5 L |
AKUMENTIS HEALTHCARE LIMITED | 2010 | ₹ 11.5 L | |
UNOSOURCE PHARMA LIMITED | Delhi | 2013 | ₹ 18.0 Cr |
DELCURE LIFESCIENCES LIMITED | 2013 | ₹ 50.0 L | |
AMAZING RESEARCH LABORATORIES LIMITED | Delhi | 1998 | ₹ 5.0 L |
PLENTEOUS PHARMACEUTICALS LIMITED | Delhi | 2008 | ₹ 5.0 L |
MAY AND BAKER PHARMACEUTICALS LIMITED | Delhi | 2006 | ₹ 5.0 L |
NICHOLAS HEALTHCARE LIMITED | Delhi | 2009 | ₹ 10.8 L |
Read more
The incorporation date of AKUMS DRUGS AND PHARMACEUTICALS LIMITED is 19 April, 2004
The authorized share capital of AKUMS DRUGS AND PHARMACEUTICALS LIMITED is INR ₹ 40.0 Cr.
The paid-up capital of AKUMS DRUGS AND PHARMACEUTICALS LIMITED is INR ₹ 31.5 Cr.
The registered address of AKUMS DRUGS AND PHARMACEUTICALS LIMITED is 304 MOHAN PLACELSC SARASWATI VIHAR, DELHI, Delhi, India, 110034 - 110034
The CIN number of AKUMS DRUGS AND PHARMACEUTICALS LIMITED is L24239DL2004PLC125888.